Why the big pharma player Boehringer Ingelheim chose DexLeChem
Boehringer Ingelheim scouted globally for a technology provider in order to support their in-house process development and manufacturing departments. They chose DexLeChem due to our outstanding expertise in STEM & sustainability.
Our mission is to systematically skim the potential of Green Chemistry for our customers with the aid of digital tools. This is convincing:
Dr. Maren Fürst – Pharmaceutical + Chemical Manufact., @Boehringer Ingelheim
„By linking [together] chemical and process engineering expertise combined with excellent statistical analysis of huge data sets and the capabilities of applying rapid prototyping, DexLeChem unveiled significant new insights that will help to further improve the production of one of our intermediate steps in our API production!”
Dr. Richard Ehlenz – Chemical Process Development, @Boehringer Ingelheim
„DexLeChem demonstrates how digitalization in API manufacturing creates values!”
About Boehringer Ingelheim:
Boheringer Ingelheim is a privately owned pharmaceutical company based in Ingelheim, Germany and with a revenue of ~15.9 bn € in 2017 it is one of the biggest pharmaceutical companies in the world.